Runda Medical(SH:603108) Zheng Quan Zhi Xing·2025-06-13 10:30Core Viewpoint - The company plans to increase the estimated amount of daily related party transactions for 2025 due to business development needs, ensuring that this will not affect its independence or reliance on related parties [1][2]. Group 1: Increase in Related Party Transactions - The company intends to increase the estimated amount of daily related party transactions for 2025 from 500 million RMB to 6.9 billion RMB, primarily due to new product demands from a related party, Guorun Medical Supply Chain Service (Shanghai) Co., Ltd [1]. - The increase in related party transactions has been approved by the board of directors and does not require shareholder meeting approval [1]. Group 2: Related Party Information - Guorun Medical Supply Chain Service (Shanghai) Co., Ltd is a subsidiary of a company in which the company holds shares, and it specializes in providing comprehensive services for medical laboratories [1]. - As of December 31, 2024, Guorun Supply Chain had total assets of 2.44 billion RMB and net assets of 734.38 million RMB, with an annual revenue of 1.00 billion RMB [1]. Group 3: Transaction Purpose and Impact - The related party transactions are necessary for the company's normal business operations and are conducted on fair and voluntary terms, ensuring no harm to the interests of the company or its shareholders [2]. - The pricing policy for these transactions is based on market fair prices, and they do not significantly impact the company's assets or profit situation [2].